PMRS Inc
PMRS Inc is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at PMRS Inc.
PMRS Inc is a company.
Key people at PMRS Inc.
Key people at PMRS Inc.
PMRS Inc. is a full-service contract manufacturer specializing in pharmaceutical products, providing cGMP-compliant services from clinical supply manufacturing to commercial-scale production, including analytical services and quality assurance.[1][2][3][4][6] Based in Horsham, Pennsylvania, with approximately 40 employees and $12.9 million in revenue, the company serves major pharmaceutical clients by delivering high-quality products at the lowest possible cost through streamlined processes, advanced technology, and over 30 years of experience.[1][3][4] It supports the development and production of investigational drugs, NDA-approved commercial products, and international approvals, emphasizing efficiency, customization, and proactive problem-solving.[2][4][6]
PMRS Inc. was incorporated in September 1994 by Edwin R. Thompson, who remains the owner and President of the privately held company.[3][4][6] Starting with just six full-time employees on its first project in December 1994, it has grown to around 30-40 employees and completed over 550 projects.[1][3][4] The company evolved from a small supplier into a world-class provider of pharmaceutical manufacturing and research services, investing in top talent, state-of-the-art facilities, and technologies while maintaining a focus on surpassing industry standards in cGMP compliance and cost efficiency.[2][4][6]
PMRS Inc. operates in the contract development and manufacturing organization (CDMO) segment of the pharmaceutical industry, riding trends toward outsourced manufacturing to accelerate drug development amid rising R&D costs and regulatory pressures.[1][2][3] Its timing aligns with growing demand for agile, cost-effective cGMP services as biotech firms scale from clinical trials to commercialization, especially for small-batch and specialty drugs.[4][6] Market forces like supply chain localization in the U.S., emphasis on Quality by Design, and sustainability in pharma production favor PMRS's Pennsylvania-based facility and efficiency focus, enabling it to support ecosystem growth by partnering with big pharma and innovators on approvals and production.[2][4][6]
PMRS Inc. is poised for steady expansion by leveraging its niche in efficient, high-standard CDMOs, potentially growing through partnerships at events like those in 2025 and further tech upgrades for hydrogen power or AI-driven analytics.[4][6] Trends such as personalized medicine, biologics scaling, and stricter ESG requirements will shape its path, amplifying demand for its low-cost, green manufacturing.[4] Its influence may evolve by enabling more startups and majors to bring drugs to market faster, solidifying its role as a reliable backbone in U.S. pharma production—much like its journey from six employees to hundreds of projects.
